Hung T. Khong, MD

home / authors / hung-t-khong-md

Articles

Hung Khong, MD, of Moffitt Cancer Center

Dr. Khong on the Importance of BRCA Testing in Breast Cancer

Hung T. Khong, MD

August 16th 2021

Hung Khong, MD, underscores the importance of testing for BRCA mutations in patients with breast cancer.

Dr. Khong on the Potential Benefit of IO/Endocrine Therapy in ER+ Breast Cancer

Hung T. Khong, MD

August 11th 2020

Hung Khong, MD, discusses the potential benefit of combining immunotherapy with endocrine therapy in estrogen receptor–positive, HER2-negative breast cancer.

Dr. Khong on Endocrine Therapy Combinations in ER+/HER2- Breast Cancer

Hung T. Khong, MD

July 31st 2020

Hung Khong, MD, discusses antiestrogen and immunotherapy combinations in ER-positive, HER2-negative breast cancer.

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Hung T. Khong, MD

March 30th 2018

Hung T. Khong, MD, medical oncologist, Moffitt Cancer Center, discusses the use of neoadjuvant endocrine therapy.

Resection and Reconstruction of a Solitary Sternal Metastasis After Mastectomy for Breast Cancer: A Case Report and Review of the Literature

Ramona Hagmaier, MHS, PA-C;Hung T. Khong, MD;Carl Maltese, MD;Randy D. Proffitt, MD;Adam I. Riker, MD

March 3rd 2011

In May 2005, a 25-year-old female presented to her primary care physician complaining of a newly palpable breast mass that had grown to several centimeters over the course of a few months.